TrialCancer chemotherapy and pharmacology2022

Integrated exposure-response analysis of efficacy and safety of lurbinectedin to support the dose regimen in small-cell lung cancer.

Carlos Fernández-Teruel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.